LipnickRJBuringJEHennekensCH. Oral contraceptives and breast cancer. A prospective cohort study. JAMA1986; 255: 58–61.
2.
Boston Collaborative Drug Surveillance Program. Reserpine and breast cancer. Lancet1974; 2: 669–71.
3.
HeinonenOPShapiroSTuominenL. Reserpine use in relation to breast cancer. Lancet1974; 2: 675–7.
4.
ArmstrongBStevensNDollR. Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. Lancet1974; 2: 672–5.
5.
HorwitzRIFeinsteinAR. Exclusion bias and the false relationship of reserpine and breast cancer. Arch Intern Med1985; 145: 1873–5.
6.
DurrerJDLieKIVan CapelleFJL. Effect of sodium nitroprusside on mortality in acute myocardial infarction. N Engl J Med1982; 306: 1121–8.
7.
CohnJNFranciosaJAFrancisGS. Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure. N Engl J Med1982; 306: 1129–35.
8.
WilsonPWFGarrisonRJCastelliWP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med1985; 313: 1038–43.
9.
StampferMJWillettWCColditzGA. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med1985; 313: 1044–9.
10.
PassamaniER. Nitroprusside in myocardial infarction (editorial). N Engl J Med1982; 306: 1168–70.
11.
BailarJC. When research results are in conflict (editorial). N Engl J Med1985; 313: 1080–1.
12.
ChalmersTCCelanoPSacksHS. Bias in treatment assignment in controlled clinical trials. N Engl J Med1983; 309: 1358–61.
